TY - JOUR AU - Berntorp, E. AU - Boulyjenkov, V. AU - Brettler, D. AU - Chandy, M. AU - Jones, P. AU - Lee, C. PY - 1995 DA - 1995// TI - Modern treatment of haemophilia JO - Bull World Health Organ VL - 73 ID - Berntorp1995 ER - TY - JOUR AU - Giangrande, P. AU - Seitz, R. AU - Behr-Gross, M. E. AU - Berger, K. AU - Hilger, A. AU - Klein, H. PY - 2014 DA - 2014// TI - Kreuth III: European consensus proposals for treatment of haemophilia with coagulation factor concentrates JO - Haemophilia VL - 20 UR - https://doi.org/10.1111/hae.12440 DO - 10.1111/hae.12440 ID - Giangrande2014 ER - TY - JOUR AU - Richards, M. AU - Williams, M. AU - Chalmers, E. AU - Liesne, R. AU - Collins, P. AU - Vidler, V. PY - 2010 DA - 2010// TI - Paediatric Working Party of the United Kingdom Haemophilia Doctors’ Organisation. A United Kingdom Haemophilia Centre Doctors’ Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A JO - Br J Haematol VL - 149 UR - https://doi.org/10.1111/j.1365-2141.2010.08139.x DO - 10.1111/j.1365-2141.2010.08139.x ID - Richards2010 ER - TY - JOUR AU - Blanchette, V. S. AU - Key, N. S. AU - Ljung, L. R. AU - Manco-Johnson, M. J. AU - Berg, H. M. AU - Srivastava, A. PY - 2014 DA - 2014// TI - Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders. Definitions in hemophilia: communication from the SSC of the ISTH JO - J Thromb Haemost VL - 12 UR - https://doi.org/10.1111/jth.12672 DO - 10.1111/jth.12672 ID - Blanchette2014 ER - TY - JOUR AU - Manco-Johnson, M. J. AU - Abshire, T. C. AU - Shapiro, A. D. AU - Riske, B. AU - Hacker, M. R. AU - Kilcoyne, R. PY - 2007 DA - 2007// TI - Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMoa067659 DO - 10.1056/NEJMoa067659 ID - Manco-Johnson2007 ER - TY - JOUR AU - Giangrande, P. AU - Calizzani, G. AU - Menichini, I. AU - Candura, F. AU - Mannucci, P. M. AU - Makris, M. PY - 2014 DA - 2014// TI - The European standards of Haemophilia Centres JO - Blood Transfus VL - 12 ID - Giangrande2014 ER - TY - JOUR AU - Clausen, N. AU - Petrini, P. AU - Claeyssens-Donadel, S. AU - Gouw, S. C. AU - Liesner, R. PY - 2014 DA - 2014// TI - Similar bleeding phenotype in young children with haemophilia A or B: a cohort study JO - Haemophilia VL - 20 UR - https://doi.org/10.1111/hae.12470 DO - 10.1111/hae.12470 ID - Clausen2014 ER - TY - JOUR AU - Astermark, J. AU - Petrini, P. AU - Tengborn, L. AU - Schulman, S. AU - Ljung, R. AU - Berntorp, E. PY - 1999 DA - 1999// TI - Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized JO - Br J Haematol VL - 105 UR - https://doi.org/10.1046/j.1365-2141.1999.01463.x DO - 10.1046/j.1365-2141.1999.01463.x ID - Astermark1999 ER - TY - JOUR AU - Feldman, B. M. AU - Pai, M. AU - Rivard, G. E. AU - Israels, S. AU - Poon, M. C. AU - Demers, C. PY - 2006 DA - 2006// TI - Tailored prophylaxis in severe haemophilia A: interim results from the first 5 year of the Canadian Hemophilia Primary Prophylaxis Study JO - J Thromb Haemost VL - 4 UR - https://doi.org/10.1111/j.1538-7836.2006.01953.x DO - 10.1111/j.1538-7836.2006.01953.x ID - Feldman2006 ER - TY - JOUR AU - Kraft, J. AU - Blanchette, V. AU - Babyn, P. AU - Feldman, B. AU - Cloutier, S. AU - Israels, S. AU - Pai, M. PY - 2012 DA - 2012// TI - Magnetic resonance imaging and joint outcomes in boys with severe hemophilia A treated with tailored primary prophylaxis in Canada JO - J Thromb Haemost VL - 10 UR - https://doi.org/10.1111/jth.12025 DO - 10.1111/jth.12025 ID - Kraft2012 ER - TY - JOUR AU - Stieltjes, N. AU - Calvez, T. AU - Demiguel, V. AU - Torchet, M. F. AU - Briquel, M. E. AU - Fressinaud, E. AU - Claeyssens, S. PY - 2005 DA - 2005// TI - French ICH Study Group. Intracranial haemorrhages in French haemophilia patients (1991–2001): clinical presentation, management and prognosis factors for death JO - Haemophilia VL - 11 UR - https://doi.org/10.1111/j.1365-2516.2005.01090.x DO - 10.1111/j.1365-2516.2005.01090.x ID - Stieltjes2005 ER - TY - JOUR AU - Traivaree, C. AU - Blanchette, V. AU - Armstrong, D. AU - Floros, G. AU - Stain, A. M. AU - Carcao, M. D. PY - 2007 DA - 2007// TI - Intracranial bleeding in haemophilia beyond the neonatal period--the role of CT imaging in suspected intracranial bleeding JO - Haemophilia VL - 13 UR - https://doi.org/10.1111/j.1365-2516.2007.01545.x DO - 10.1111/j.1365-2516.2007.01545.x ID - Traivaree2007 ER - TY - JOUR AU - Ljung, R. C. PY - 2008 DA - 2008// TI - Intracranial haemorrhage in haemophilia A and B JO - Br J Haematol VL - 140 UR - https://doi.org/10.1111/j.1365-2141.2007.06949.x DO - 10.1111/j.1365-2141.2007.06949.x ID - Ljung2008 ER - TY - JOUR AU - Witmer, C. AU - Presley, R. AU - Kulkarni, R. AU - Soucie, J. M. AU - Manno, C. S. AU - Raffini, L. PY - 2011 DA - 2011// TI - Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States JO - Br J Haematol VL - 152 UR - https://doi.org/10.1111/j.1365-2141.2010.08469.x DO - 10.1111/j.1365-2141.2010.08469.x ID - Witmer2011 ER - TY - JOUR AU - Kreuz, W. AU - Escuriola-Ettingshausen, C. AU - Funk, M. AU - Schmidt, H. AU - Kornhuber, B. PY - 1998 DA - 1998// TI - When should prophylactic treatment in patients with haemophilia A and B start?--The German experience JO - Haemophilia VL - 4 UR - https://doi.org/10.1046/j.1365-2516.1998.440413.x DO - 10.1046/j.1365-2516.1998.440413.x ID - Kreuz1998 ER - TY - JOUR AU - Skinner, M. W. PY - 2012 DA - 2012// TI - WFH: Closing the global gap – achieving optimal care JO - Haemophilia VL - 18 UR - https://doi.org/10.1111/j.1365-2516.2012.02822.x DO - 10.1111/j.1365-2516.2012.02822.x ID - Skinner2012 ER - TY - JOUR AU - Fischer, K. AU - Steen Carlsson, K. AU - Petrini, P. AU - Holmström, M. AU - Ljung, R. AU - Berg, H. M. AU - Berntorp, E. PY - 2013 DA - 2013// TI - Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s JO - Blood VL - 122 UR - https://doi.org/10.1182/blood-2012-12-470898 DO - 10.1182/blood-2012-12-470898 ID - Fischer2013 ER - TY - JOUR AU - Soreff, J. AU - Blombäck, M. PY - 1980 DA - 1980// TI - Arthropathy in children with severe hemophilia A JO - Acta Paediatr Scand VL - 69 UR - https://doi.org/10.1111/j.1651-2227.1980.tb07341.x DO - 10.1111/j.1651-2227.1980.tb07341.x ID - Soreff1980 ER - TY - JOUR AU - Pettersson, H. AU - Ahlberg, A. AU - Nilsson, I. M. PY - 1980 DA - 1980// TI - A radiologic classification of hemophilic arthropathy JO - Clin Orthop Relat Res VL - 149 ID - Pettersson1980 ER - TY - JOUR AU - Lundin, B. AU - Ljung, R. AU - Pettersson, H. PY - 2005 DA - 2005// TI - MRI scores of ankle joints in children with haemophilia--comparison with clinical data JO - Haemophilia VL - 11 UR - https://doi.org/10.1111/j.1365-2516.2005.01061.x DO - 10.1111/j.1365-2516.2005.01061.x ID - Lundin2005 ER - TY - JOUR AU - Collins, P. W. AU - Blanchette, V. S. AU - Fischer, K. AU - Björkman, S. AU - Oh, M. AU - Fritsch, S. PY - 2009 DA - 2009// TI - rAHF–PFM Study Group. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A JO - J Thromb Haemost VL - 7 UR - https://doi.org/10.1111/j.1538-7836.2008.03270.x DO - 10.1111/j.1538-7836.2008.03270.x ID - Collins2009 ER - TY - JOUR AU - Collins, P. W. AU - Björkman, S. AU - Fischer, K. AU - Blanchette, V. AU - Oh, M. AU - Schroth, P. PY - 2010 DA - 2010// TI - Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens JO - J Thromb Haemost VL - 8 UR - https://doi.org/10.1111/j.1538-7836.2009.03703.x DO - 10.1111/j.1538-7836.2009.03703.x ID - Collins2010 ER - TY - JOUR AU - Powell, J. AU - Shapiro, A. AU - Ragni, M. AU - Negrier, C. AU - Windyga, J. AU - Ozelo, M. PY - 2015 DA - 2015// TI - Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates JO - Br J Haematol VL - 168 UR - https://doi.org/10.1111/bjh.13109 DO - 10.1111/bjh.13109 ID - Powell2015 ER - TY - JOUR AU - Morado, M. AU - Villar, A. AU - Jiménez Yuste, V. AU - Quintana, M. AU - Hernandez, N. F. PY - 2005 DA - 2005// TI - Prophylactic treatment effects on inhibitor risk: experience in one centre JO - Haemophilia VL - 11 UR - https://doi.org/10.1111/j.1365-2516.2005.00921.x DO - 10.1111/j.1365-2516.2005.00921.x ID - Morado2005 ER - TY - JOUR AU - Santagostino, E. AU - Mancuso, M. E. AU - Rocino, A. AU - Mancuso, G. AU - Mazzucconi, M. G. AU - Tagliaferri, A. PY - 2005 DA - 2005// TI - Environmental risk factors for inhibitor development in children with haemophilia A: a case–control study JO - Br J Haematol VL - 130 UR - https://doi.org/10.1111/j.1365-2141.2005.05605.x DO - 10.1111/j.1365-2141.2005.05605.x ID - Santagostino2005 ER - TY - JOUR AU - Gouw, S. C. AU - Bom, J. G. AU - Berg, M. H. PY - 2007 DA - 2007// TI - Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-11-056291 DO - 10.1182/blood-2006-11-056291 ID - Gouw2007 ER - TY - JOUR AU - Kurnik, K. AU - Auerswald, G. AU - Kreuz, W. PY - 2014 DA - 2014// TI - Inhibitors and prophylaxis in paediatric haemophilia patients: Focus on the German experience JO - Thromb Res VL - 134 UR - https://doi.org/10.1016/j.thromres.2013.10.017 DO - 10.1016/j.thromres.2013.10.017 ID - Kurnik2014 ER - TY - JOUR AU - Gouw, S. C. AU - Berg, H. M. AU - Fischer, K. AU - Auerswald, G. AU - Carcao, M. AU - Chalmers, E. PY - 2013 DA - 2013// TI - Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-09-457036 DO - 10.1182/blood-2012-09-457036 ID - Gouw2013 ER - TY - JOUR AU - Manco-Johnson, M. J. AU - Kempton, C. L. AU - Reding, M. T. AU - Lissitchkov, T. AU - Goranov, S. AU - Gercheva, L. PY - 2013 DA - 2013// TI - Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART) JO - J Thromb Haemost VL - 11 UR - https://doi.org/10.1111/jth.12202 DO - 10.1111/jth.12202 ID - Manco-Johnson2013 ER - TY - JOUR AU - Khawaji, M. AU - Astermark, J. AU - Berntorp, E. PY - 2012 DA - 2012// TI - Lifelong prophylaxis in a large cohort of adult patients with severe haemophilia: a beneficial effect on orthopaedic outcome and quality of life JO - Eur J Haematol VL - 88 UR - https://doi.org/10.1111/j.1600-0609.2012.01750.x DO - 10.1111/j.1600-0609.2012.01750.x ID - Khawaji2012 ER - TY - JOUR AU - Aledort, L. M. AU - Haschmeyer, R. H. AU - Pettersson, H. PY - 1994 DA - 1994// TI - A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group JO - J Intern Med VL - 236 UR - https://doi.org/10.1111/j.1365-2796.1994.tb00815.x DO - 10.1111/j.1365-2796.1994.tb00815.x ID - Aledort1994 ER - TY - JOUR AU - Oldenburg, J. AU - Albert, T. PY - 2014 DA - 2014// TI - Novel products for haemostasis - current status JO - Haemophilia VL - 20 UR - https://doi.org/10.1111/hae.12428 DO - 10.1111/hae.12428 ID - Oldenburg2014 ER - TY - JOUR AU - Powell, J. S. AU - Pasi, K. J. AU - Ragni, M. V. PY - 2013 DA - 2013// TI - Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1305074 DO - 10.1056/NEJMoa1305074 ID - Powell2013 ER - TY - JOUR AU - Santagostino, E. AU - Martinowitz, U. AU - Lissitchkov, T. PY - 2016 DA - 2016// TI - Long acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial JO - Blood VL - 127 UR - https://doi.org/10.1182/blood-2015-09-669234 DO - 10.1182/blood-2015-09-669234 ID - Santagostino2016 ER - TY - JOUR AU - Collins, P. W. AU - Young, G. AU - Knobe, K. PY - 2014 DA - 2014// TI - Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2014-05-573055 DO - 10.1182/blood-2014-05-573055 ID - Collins2014 ER - TY - JOUR AU - Young, G. AU - Mahlangu, J. N. PY - 2016 DA - 2016// TI - Extended half-life clotting factor concentrates: results from published clinical trials JO - Haemophilia VL - 22 UR - https://doi.org/10.1111/hae.13028 DO - 10.1111/hae.13028 ID - Young2016 ER - TY - JOUR AU - Leissinger, C. AU - Gringeri, A. AU - Antmen, B. AU - Berntorp, E. AU - Biasoli, C. AU - Carpenter, S. AU - Cortesi, P. AU - Jo, H. AU - Kavakli, K. AU - Lassila, R. AU - Morfini, M. AU - Négrier, C. AU - Rocino, A. AU - Schramm, W. AU - Serban, M. AU - Uscatescu, M. V. AU - Windyga, J. AU - Zülfikar, B. AU - Mantovani, L. PY - 2011 DA - 2011// TI - Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1104435 DO - 10.1056/NEJMoa1104435 ID - Leissinger2011 ER - TY - JOUR AU - Antunes, S. V. AU - Tangada, S. AU - Stasyshyn, O. AU - Mamonov, V. AU - Phillips, J. AU - Guzman-Becerra, N. AU - Grigorian, A. AU - Ewenstein, B. AU - Wong, W. Y. PY - 2014 DA - 2014// TI - Randomized comparison of prophylaxis and on-demand regimens with FEIBA NF in the treatment of haemophilia A and B with inhibitors JO - Haemophilia VL - 20 UR - https://doi.org/10.1111/hae.12246 DO - 10.1111/hae.12246 ID - Antunes2014 ER - TY - JOUR AU - Konkle, B. A. AU - Ebbesen, L. S. AU - Erhardtsen, E. AU - Bianco, R. P. AU - Lissitchkov, T. AU - Rusen, L. AU - Serban, M. A. PY - 2007 DA - 2007// TI - Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors JO - J Thromb Haemost VL - 5 UR - https://doi.org/10.1111/j.1538-7836.2007.02663.x DO - 10.1111/j.1538-7836.2007.02663.x ID - Konkle2007 ER - TY - JOUR AU - López-Fernández, M. F. AU - Altisent Roca, C. AU - Álvarez-Román, M. T. AU - Canaro Hirnyk, M. I. AU - Mingot-Castellano, M. E. AU - Jiménez-Yuste, V. AU - Cid Haro, A. R. AU - Pérez-Garrido, R. AU - Sedano Balbas, C. PY - 2016 DA - 2016// TI - Spanish Consensus Guidelines on prophylaxis with bypassing agents in patients with haemophilia and inhibitors JO - Thromb Haemost. VL - 115 UR - https://doi.org/10.1160/TH15-07-0568 DO - 10.1160/TH15-07-0568 ID - López-Fernández2016 ER - TY - JOUR AU - Ljung, R. AU - Gretenkort, A. N. PY - 2015 DA - 2015// TI - The current status of prophylactic replacement therapy in children and adults with haemophilia JO - Br J Haematol VL - 169 UR - https://doi.org/10.1111/bjh.13365 DO - 10.1111/bjh.13365 ID - Ljung2015 ER -